False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer

K. Athanassiadi, A. Makrygianni, E. Balis, N. Alevizopoulos, M. Vaslamatzis, C. Vourlakou (Athens, Greece)

Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session: Diagnosis, imaging and surgery for thoracic tumours
Session type: Thematic Poster Session
Number: 2770
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Athanassiadi, A. Makrygianni, E. Balis, N. Alevizopoulos, M. Vaslamatzis, C. Vourlakou (Athens, Greece). False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2770

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endobronchial ultrasound guided biopsy (EBUS–TBNA) for staging of patients with lung cancer without mediastinal involvement at positron emission tomography-computed tomography (PET-CT)
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016


Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007



Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009



The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002



Computed tomography in staging for lung cancer
Source: Eur Respir J 2002; 19: 40S-48S
Year: 2002



The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004

Imaging can replace mediastinoscopy: CON
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

Radiology of lung cancer
Source: Eur Respir Mon; 2009: 44: 106–135
Year: 2009

Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004

Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008


Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007



Mediastinal lymph node staging in nonsmall cell lung cancer: comparison of positron emission tomography and mediastinoscopy
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007


The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001



The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004



Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008